Archer Investment Corporation’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $973 | Hold |
20
| – | – | ﹤0.01% | 1038 |
|
|
2025
Q1 | $681 | Hold |
20
| – | – | ﹤0.01% | 1028 |
|
|
2024
Q4 | $787 | Hold |
20
| – | – | ﹤0.01% | 1017 |
|
|
2024
Q3 | $940 | Sell |
20
-200
| -91% | -$9.4K | ﹤0.01% | 987 |
|
|
2024
Q2 | $11.9K | Hold |
220
| – | – | ﹤0.01% | 633 |
|
|
2024
Q1 | $15K | Hold |
220
| – | – | ﹤0.01% | 585 |
|
|
2023
Q4 | $13.8K | Buy |
220
+200
| +1,000% | +$12.5K | ﹤0.01% | 597 |
|
|
2023
Q3 | $908 | Hold |
20
| – | – | ﹤0.01% | 935 |
|
|
2023
Q2 | $1.12K | Sell |
20
-135
| -87% | -$7.58K | ﹤0.01% | 902 |
|
|
2023
Q1 | $7.01K | Hold |
155
| – | – | ﹤0.01% | 617 |
|
|
2022
Q4 | $6.3K | Hold |
155
| – | – | ﹤0.01% | 593 |
|
|
2022
Q3 | $10.1K | Hold |
155
| – | – | ﹤0.01% | 527 |
|
|
2022
Q2 | $9.42K | Hold |
155
| – | – | ﹤0.01% | 538 |
|
|
2022
Q1 | $9.53K | Sell |
155
-2,965
| -95% | -$182K | ﹤0.01% | 548 |
|
|
2021
Q4 | $236K | Hold |
3,120
| – | – | 0.08% | 207 |
|
|
2021
Q3 | $349K | Hold |
3,120
| – | – | 0.13% | 170 |
|
|
2021
Q2 | $505K | Hold |
3,120
| – | – | 0.2% | 117 |
|
|
2021
Q1 | $380K | Buy |
+3,120
| New | +$380K | 0.16% | 148 |
|
|
2019
Q4 | – | Sell |
-7,500
| Closed | -$307K | – | 611 |
|
|
2019
Q3 | $307K | Buy |
+7,500
| New | +$307K | 0.19% | 140 |
|